• Accelerating TB vaccine Research & Development through partnership
  • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Become a TBVI partner
        • Access to services
        • Conferences, meetings and workshops
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • MTBVAC in Newborns
        • MTBVAC in newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Archives

    Monthly Archive for: "August, 2019"
    Home / 2019 / August
      0
    By Marit Holleman
    In Uncategorized Posted August 30, 2019

    Insights and challenges in tuberculosis vaccine development

    Recently the article ‘Insights and challenges in tuberculosis vaccine development’ by Prof. Helen McShane was published in The Lancet.

    Read More
      0
    By Marit Holleman
    In Uncategorized Posted August 27, 2019

    Vacancy: The VALIDATE Network is looking for a Postdoctoral Bioinformatician/Computational Biologist

    The VALIDATE Network has a vacancy for a Postdoctoral Bioinformatician/Computational Biologist, based at the Jenner Institute at Oxford University. VALIDATE is an international network of [...]

    Read More
      0
    By Cora Agterdenbosch
    In Uncategorized Posted August 20, 2019

    Press release: Results from new trial of the candidate TB vaccine MTBVAC offer hope for control of tuberculosis in infants

    Press release: Results from new trial of the candidate TB vaccine MTBVAC offer hope for control of tuberculosis in infants First trial of a new live attenuated Mycobacterium tuberculosis [...]

    Read More
    Load More
    Menu
    • Home
    • About us
    • What we do
    • How we work
    • For researchers and vaccine developers
    • For funders
    • Pipeline of vaccines
    • News
    TuBerculosis Vaccine Initiative (TBVI)

    Runderweg 6
    8219 PK Lelystad
    The Netherlands
    Email: info@tbvi.eu
    Phone: +31 320 277 550

    © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

    Start typing and press Enter to search

    Cookies

    This website uses cookies that help the website function

    OK No